Jerry Kanellos
Vermogen: 9 371 $ op 31-10-2026
Vermogen: 9 371 $ op 31-10-2026
Jerry Kanellos currently works at Immuron Canada Ltd., as Director from 2018 and Immuron Ltd., as Chief Operating & Scientific Officer from 2022.
Dr. Kanellos also formerly worked at CSL Ltd., as Head-Research & Development and Transbio Ltd., as Chief Operating Officer from 2008 to 2012.
Dr. Kanellos received his doctorate degree from the University of Melbourne.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMURON LIMITED 0,1% | 08-09-2026 | 333.000 ( 0,1% ) | 9 371 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMURON LIMITED | Operationeel Directeur | 01-07-2015 |
Immuron Canada Ltd. | Directeur/Bestuurslid | 01-04-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Transbio Ltd. | Operationeel Directeur | 01-01-2012 |
| CSL LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Transbio Ltd. | |
Immuron Canada Ltd. |
Kies jouw editie
Alle financiële informatie op nationaal niveau